Literature DB >> 25693730

Hypomagnesaemia and its potential impact on thiamine utilisation in patients with alcohol misuse at the Alice Springs Hospital.

Kylie Maree Dingwall1, Jennifer Flavia Delima, Debra Gent, Robert Gordon Batey.   

Abstract

INTRODUCTION AND AIMS: Alcohol rapidly reduces thiamine among alcohol-dependent individuals. Poor diet and alcohol's impact on absorption, storage, activation and excretion of thiamine are thought to be the mechanisms. Previous literature identifies magnesium as an important cofactor in thiamine utilisation, which might also be compromised in alcohol dependent patients. The aim was to describe the thiamine status and clinical profile for a sample of heavy alcohol users entering the Alice Springs Hospital in the Northern Territory of Australia and to examine the relationship between thiamine deficiency, magnesium deficiency and cognitive functioning. DESIGN AND METHODS: Cross-sectional study examining thiamine pyrophosphate (TPP) and magnesium concentrations for a sample of 62 males and 43 females (N = 105; n = 88 Aboriginal, n = 13 non-Indigenous). Cognition was assessed using the Rowland Universal Dementia Assessment Scale.
RESULTS: TPP concentrations were within or above the reference range. Aboriginal patients had significantly lower TPP than non-Indigenous patients. A marginally significant difference was found between individuals with thiamine supplementation recorded within the previous 20 days compared with those without. Mean serum magnesium was in the low normal range with magnesium deficiency (i.e. <0.80 mmol L(-1)) present in 48% of those tested. Serum magnesium (but not TPP) concentrations correlated positively with cognitive test scores. DISCUSSION AND
CONCLUSIONS: Despite increased exposure to risk factors for Wernicke Korsakoff Syndrome, no patient had TPP concentrations below the reference range. High patient readmission and aggressive thiamine treatment policies may explain this finding. However, low magnesium may be prevalent and could contribute to impaired thiamine utilisation.
© 2015 Australasian Professional Society on Alcohol and other Drugs.

Entities:  

Keywords:  Wernicke Korsakoff Syndrome; cognition; hypomagnesaemia; magnesium; thiamine

Mesh:

Substances:

Year:  2015        PMID: 25693730     DOI: 10.1111/dar.12237

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  3 in total

1.  Randomised trial of intravenous thiamine and/or magnesium sulphate administration on erythrocyte transketolase activity, lactate concentrations and alcohol withdrawal scores.

Authors:  Donogh Maguire; Alana Burns; Dinesh Talwar; Anthony Catchpole; Fiona Stefanowicz; David P Ross; Peter Galloway; Alastair Ireland; Gordon Robson; Michael Adamson; Lesley Orr; Joanna-Lee Kerr; Xenofon Roussis; Eoghan Colgan; Ewan Forrest; David Young; Donald C McMillan
Journal:  Sci Rep       Date:  2022-04-28       Impact factor: 4.996

2.  What is the optimum thiamine dose to treat or prevent Wernicke's encephalopathy or Wernicke-Korsakoff syndrome? Results of a randomized controlled trial.

Authors:  Kylie M Dingwall; Jennifer F Delima; Paula Binks; Robert Batey; Stephen C Bowden
Journal:  Alcohol Clin Exp Res       Date:  2022-05-10       Impact factor: 3.928

3.  A prospective evaluation of thiamine and magnesium status in relation to clinicopathological characteristics and 1-year mortality in patients with alcohol withdrawal syndrome.

Authors:  Donogh Maguire; Dinesh Talwar; Alana Burns; Anthony Catchpole; Fiona Stefanowicz; Gordon Robson; David P Ross; David Young; Alastair Ireland; Ewan Forrest; Peter Galloway; Michael Adamson; Eoghan Colgan; Hannah Bell; Lesley Orr; Joanna-Lee Kerr; Xen Roussis; Donald C McMillan
Journal:  J Transl Med       Date:  2019-11-21       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.